Description
PET-CT RADIOPHARMACEUTICALS - OY 1 - DECREASE FUNDING
Base award description: RADIOPHARMACEUTICALS FOR RLR VAMC.
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-10-01+$105,770= $105,770
- Mod 12012-04-09+$105,915= $211,685
- Mod P000022012-10-01+$234,550= $446,235
- Mod P000032012-10-29-$27,642= $418,593
- Mod P000042013-03-07+$9,184= $427,777
- Mod P000052013-08-27-$10,000= $417,777
- Mod P000062014-01-21-$19,948= $397,829
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-10-01 | +$105,770 | $105,770 | RADIOPHARMACEUTICALS FOR RLR VAMC. |
| Mod 1· FUNDING ONLY ACTION | 2012-04-09 | +$105,915 | $211,685 | INCREASE ESTIMATED QUANTITIES OF RADIOPHARMACEUTICALS. |
| Mod P00002· EXERCISE AN OPTION | 2012-10-01 | +$234,550 | $446,235 | PET-CT RADIOPHARMACEUTICALS - OY 1 |
| Mod P00003· FUNDING ONLY ACTION | 2012-10-29 | −$27,642 | $418,593 | PET-CT RADIOPHARMACEUTICALS - OY 1 |
| Mod P00004· FUNDING ONLY ACTION | 2013-03-07 | +$9,184 | $427,777 | PET-CT RADIOPHARMACEUTICALS - OY 1 - INCREASE FUNDS |
| Mod P00005· FUNDING ONLY ACTION | 2013-08-27 | −$10,000 | $417,777 | PET-CT RADIOPHARMACEUTICALS - OY 1 - DECREASE FUNDING |
| Mod P00006· FUNDING ONLY ACTION | 2014-01-21 | −$19,948 | $397,829 | PET-CT RADIOPHARMACEUTICALS - OY 1 - DECREASE FUNDING |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Z63RLN31BEE5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24726P0726 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q527 · MEDICAL- NUCLEAR MEDICINE | $1,575,677 | FY2026 |
| 36C25726P0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $40,573 | FY2026 |
| 36C24726C0041 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q527 · MEDICAL- NUCLEAR MEDICINE | $288,295 | FY2026 |
| 36C24726P0609 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q522 · MEDICAL- RADIOLOGY | $241,418 | FY2026 |
| 36C24226N0561 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $226,562 | FY2026 |
| 36C24226D0062 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 583-INDIANAPOLIS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F0847 | ACTELION PHARMACEUTICALS US, INC. | 583-INDIANAPOLIS | $4,614 | FY2016 |
| VA25116F0730 | CSL BEHRING L.L.C. | 583-INDIANAPOLIS | $26,724 | FY2016 |
| VA25116F0509 | CSL BEHRING L.L.C. | 583-INDIANAPOLIS | $26,724 | FY2016 |
| VA25116F0406 | ROCHE DIAGNOSTICS CORPORATION | 583-INDIANAPOLIS | $17,601 | FY2016 |
| VA25116P0414 | ASD SPECIALTY HEALTHCARE, LLC | 583-INDIANAPOLIS | $35,317 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25112J0013_3600_VA251P1143_3600 · retrieved 2026-09-26.